Fiadjoe, Hope K.
Hoteit, Tamara
Jones, Harlan P.
Park, In-Woo
Chaudhary, Pankaj
Funding for this research was provided by:
National Institutes of Health (AI179337)
National Institutes of Health (CA283524)
Article History
Received: 14 August 2025
Accepted: 6 November 2025
First Online: 28 November 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the University of North Texas Health Science Center, Fort Worth, TX, USA (IRB approval number: 2023-034).
: Patient consent was waived due to the usage of deidentified and existing tumor tissues which were collected from two biorepository centers: (1) Ontario Tumour Bank in Toronto, Canada, and (2) the Alberta Cancer Research Biobank in Calgary, Canada. According to the NIH guidelines for Protection of Human Research Subjects (45 CFR 46) and our IRB protocol, this study is exempted from the Human Subjects research.
: All authors have read and approved the final manuscript and consent to its publication.
: The authors declare no competing interests.